Mohamed E. Shaker

1.3k total citations
60 papers, 1.0k citations indexed

About

Mohamed E. Shaker is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mohamed E. Shaker has authored 60 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Mohamed E. Shaker's work include Liver physiology and pathology (10 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Synthesis and biological activity (9 papers). Mohamed E. Shaker is often cited by papers focused on Liver physiology and pathology (10 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Synthesis and biological activity (9 papers). Mohamed E. Shaker collaborates with scholars based in Egypt, Saudi Arabia and Pakistan. Mohamed E. Shaker's co-authors include Tarek M. Ibrahim, Gamal Shiha, Maha E. Houssen, Sylvia A. Ashamallah, Wajahat Z. Mehal, Mohamed El‐Mesery, Khaled Zalata, Mohamed A. Abdelgawad, Ahmed A. Shaaban and Hatem A. Salem and has published in prestigious journals such as SHILAP Revista de lepidopterología, Tetrahedron and Molecules.

In The Last Decade

Mohamed E. Shaker

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed E. Shaker Egypt 20 334 201 173 172 159 60 1.0k
Simmy Thomas India 20 442 1.3× 328 1.6× 168 1.0× 47 0.3× 89 0.6× 26 1.1k
Wenhui Mo China 17 651 1.9× 337 1.7× 226 1.3× 48 0.3× 120 0.8× 43 1.3k
Marwa Hassan Egypt 16 317 0.9× 68 0.3× 64 0.4× 78 0.5× 98 0.6× 55 806
Natale D’Alessandro Italy 23 887 2.7× 104 0.5× 68 0.4× 265 1.5× 75 0.5× 57 1.6k
Manon Buist‐Homan Netherlands 20 535 1.6× 481 2.4× 301 1.7× 48 0.3× 201 1.3× 58 1.4k
Zhi Dai China 20 975 2.9× 653 3.2× 132 0.8× 80 0.5× 114 0.7× 59 1.9k
Hyun Mi Choi South Korea 13 309 0.9× 229 1.1× 116 0.7× 25 0.1× 231 1.5× 26 982
Xiaoqin Wu China 19 457 1.4× 394 2.0× 139 0.8× 82 0.5× 82 0.5× 53 1.1k

Countries citing papers authored by Mohamed E. Shaker

Since Specialization
Citations

This map shows the geographic impact of Mohamed E. Shaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed E. Shaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed E. Shaker more than expected).

Fields of papers citing papers by Mohamed E. Shaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed E. Shaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed E. Shaker. The network helps show where Mohamed E. Shaker may publish in the future.

Co-authorship network of co-authors of Mohamed E. Shaker

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed E. Shaker. A scholar is included among the top collaborators of Mohamed E. Shaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed E. Shaker. Mohamed E. Shaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdelgawad, Mohamed A., Arafa Musa, Ehab M. Mostafa, et al.. (2025). Synthesis and characterization of novel pyrazoline derivatives as dual α-amylase /α-glucosidase inhibitors: molecular modeling and kinetic study. Journal of Molecular Structure. 1339. 142350–142350. 1 indexed citations
2.
Shaker, Mohamed E., et al.. (2025). Targeting amyloid β42 aggregation using a structurally defined graphene quantum dot model: A combined molecular and biological investigation. International Journal of Biological Macromolecules. 321(Pt 1). 146205–146205.
3.
Gomaa, Hesham A. M., Mohamed E. Shaker, Sami I. Alzarea, et al.. (2025). Design, synthesis, and biological investigation of new thiazole-based derivatives as multi-targeted inhibitors endowed with antiproliferative, antioxidant, and antibacterial properties. Frontiers in Chemistry. 13. 1595997–1595997. 2 indexed citations
4.
Shaker, Mohamed E., et al.. (2023). Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib. Frontiers in Pharmacology. 14. 1212771–1212771. 2 indexed citations
5.
Abdelgawad, Mohamed A., Mohammed M. Ghoneim, Mohamed E. Shaker, et al.. (2023). Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors. ACS Omega. 8(41). 37731–37751. 19 indexed citations
6.
Shaker, Mohamed E., et al.. (2023). Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities. International Immunopharmacology. 120. 110373–110373. 3 indexed citations
7.
Gomaa, Hesham A. M., Mohamed E. Shaker, Sami I. Alzarea, et al.. (2023). Design, synthesis, and biological evaluation of indole-2-carboxamides as SARS CoV-2 main protease inhibitors. Tetrahedron. 146. 133628–133628. 3 indexed citations
8.
9.
Abdelgawad, Mohamed A., Syed Nasir Abbas Bukhari, Arafa Musa, et al.. (2022). New Sulfamethoxazole Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Cytotoxic Activity and Molecular Modeling. Pharmaceuticals. 15(9). 1134–1134. 7 indexed citations
10.
Musa, Arafa, Mohamed A. Abdelgawad, Mohamed E. Shaker, et al.. (2022). Screening and Molecular Docking of Bioactive Metabolites of the Red Sea Sponge Callyspongia siphonella as Potential Antimicrobial Agents. Antibiotics. 11(12). 1682–1682. 3 indexed citations
11.
El‐Mesery, Mohamed, et al.. (2020). The NEDD8-activating enzyme inhibition with MLN4924 sensitizes human cancer cells of different origins to apoptosis and necroptosis. Archives of Biochemistry and Biophysics. 691. 108513–108513. 11 indexed citations
12.
Shaker, Mohamed E., et al.. (2020). The c-Met inhibitor capmatinib alleviates acetaminophen-induced hepatotoxicity. International Immunopharmacology. 81. 106292–106292. 16 indexed citations
13.
Shaker, Mohamed E., et al.. (2020). Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide/galactosamine-induced hepatic damage. Biomedicine & Pharmacotherapy. 131. 110736–110736. 13 indexed citations
14.
Abdel-Dayem, Marwa A., Mohamed E. Shaker, & Nariman M. Gameil. (2019). Impact of interferon β-1b, interferon β-1a and fingolimod therapies on serum interleukins-22, 32α and 34 concentrations in patients with relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 337. 577062–577062. 7 indexed citations
15.
Shaker, Mohamed E., et al.. (2017). Repression of acetaminophen-induced hepatotoxicity by a combination of celastrol and brilliant blue G. Toxicology Letters. 275. 6–18. 24 indexed citations
16.
Houssen, Maha E., et al.. (2016). Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility. Oncology Letters. 11(3). 2182–2188. 13 indexed citations
17.
Shaker, Mohamed E., Sylvia A. Ashamallah, & Maha E. Houssen. (2014). Celastrol ameliorates murine colitis via modulating oxidative stress, inflammatory cytokines and intestinal homeostasis. Chemico-Biological Interactions. 210. 26–33. 87 indexed citations
18.
Gibreel, Ahmed, et al.. (2013). Clomiphene Citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial. Journal of Assisted Reproduction and Genetics. 30(11). 1477–1485. 12 indexed citations
19.
Shaaban, Ahmed A., Mohamed E. Shaker, Khaled Zalata, Hassan A. El‐Kashef, & Tarek M. Ibrahim. (2013). Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3. Chemico-Biological Interactions. 207. 81–91. 38 indexed citations
20.
Shaker, Mohamed E., Gamal Shiha, & Tarek M. Ibrahim. (2011). Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis. European Journal of Pharmacology. 670(2-3). 593–600. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simmy Thomas Breakdown of academic impact, for papers by Wenhui Mo Breakdown of academic impact, for papers by Marwa Hassan Breakdown of academic impact, for papers by Natale D’Alessandro Breakdown of academic impact, for papers by Manon Buist‐Homan Breakdown of academic impact, for papers by Zhi Dai Breakdown of academic impact, for papers by Hyun Mi Choi Breakdown of academic impact, for papers by Xiaoqin Wu
Rankless by CCL
2026